Stock GENI GENINCODE PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials GENinCode Plc

Equities

GENI

GB00BL97B504

Medical Equipment, Supplies & Distribution

Market Closed - London S.E.
Other stock markets
 09:05:01 10/05/2024 pm IST 		5-day change 1st Jan Change
9.625 GBX +4.05% Intraday chart for GENinCode Plc +30.51% +83.33%
04/04 GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort CI
21/03 GENinCode says ROCA recommended as ovarian cancer risk test in England AN

Valuation

Fiscal Period: December 2021 2022 2023 2024
Capitalization 1 31.14 7.426 17.03 17.03
Enterprise Value (EV) 1 16.59 -2.306 15.84 16.7
P/E ratio -4.04 x -1.25 x -1.38 x -3.75 x
Yield - - - -
Capitalization / Revenue 27 x 5.19 x 7.78 x 3.66 x
EV / Revenue 14.4 x -1.61 x 7.24 x 3.59 x
EV / EBITDA -4.84 x 0.41 x -2.38 x -3.9 x
EV / FCF -54,11,576 x - - -
FCF Yield -0% - - -
Price to Book - - - -
Nbr of stocks (in thousands) 95,817 95,817 1,76,964 1,76,964
Reference price 2 0.3250 0.0775 0.0962 0.0962
Announcement Date 17/05/22 06/06/23 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024
Net sales 1 0.9608 1.154 1.43 2.188 4.651
EBITDA 1 - -3.426 -5.634 -6.644 -4.283
EBIT 1 - -4.146 -5.899 -6.931 -4.715
Operating Margin - -359.27% -412.52% -316.77% -101.38%
Earnings before Tax (EBT) 1 - -4.136 -5.746 -6.861 -4.755
Net income 1 -1.166 -4.07 -5.92 -6.661 -4.555
Net margin -121.36% -352.69% -413.99% -304.43% -97.94%
EPS 2 - -0.0805 -0.0618 -0.0695 -0.0257
Free Cash Flow - -3.065 - - -
FCF margin - -265.6% - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 06/04/21 17/05/22 06/06/23 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 S1 2023 S2
Net sales 1 - 1.238
EBITDA 1 - -3.275
EBIT 1 - -3.337
Operating Margin - -269.55%
Earnings before Tax (EBT) 1 - -3.354
Net income 1 -3.501 -3.16
Net margin - -255.25%
EPS 2 -0.0333 -0.0330
Dividend per Share - -
Announcement Date 20/09/23 -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt 1 - - - - -
Net Cash position 1 - 14.6 9.73 1.19 0.33
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -3.07 - - -
ROE (net income / shareholders' equity) - - - -332% -583%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 1 - 0.04 0.7 0.1 0.14
Capex / Sales - 3.55% 48.95% 4.57% 3.01%
Announcement Date 06/04/21 17/05/22 06/06/23 - -
1GBP in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for GENinCode Plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
GENINCODE PLC Stock GENinCode Plc
+83.33% 21.32M
BIOMÉRIEUX Stock bioMérieux
-1.29% 12.64B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-0.47% 8.46B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+22.61% 5.27B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-2.03% 4.49B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-53.56% 3.11B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+19.30% 2.87B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+33.07% 2.31B
VITROLIFE AB Stock Vitrolife AB
-8.42% 2.23B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-3.55% 1.89B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. GENI Stock
  4. Financials GENinCode Plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW